REFERENCES
- Smith RE. The tear film complex: pathogenesis and emerging therapies for dry eyes. Cornea 2005;24:1–7.
- Gumus K, Cavanagh DH. The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca. Clin Ophthalmol 2009;3:57–67.
- Lemp MA, Foulks GN. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. Ocular Surf 2007;5:75–92.
- Crowe JH, Crowe LM. Preservation of mammalian cells-learning nature’s tricks. Nat Biotechnol 2000;18:145–146.
- Luyckx J, Baudouin C. Trehalose: an intriguing disaccharide with potential for medical application in ophthalmology. Clin Ophthalmol 2011;5:577–581.
- Tang M, Waring AJ, Hong M. Trehalose-protected lipid membranes for determining membrane protein structure and insertion. J Magn Reson 2007;184:222–227.
- Elbein AD, Pan YT, Pastuszak I et al. New insights on trehalose: a multifunctional molecule. Glycobiology 2003;13:17R–27R.
- Carpenter JF, Martin B, Crowe LM et al. Stabilization of phosphofructokinase during air-drying with sugars and sugar/transition metal mixtures. Cryobiology 1987;24:455–464.
- Crowe JH, Crowe LM, Carpenter JF et al. Stabilization of dry phospholipid bilayers and proteins by sugars. Biochem J 1987;242:1–10.
- Matsuo T. Trehalose protects corneal epithelial cells from death by drying. Br J Ophthalmol 2001;85:610–612.
- Chen W, Zhang X, Liu M et al. Trehalose protects against ocular surface disorders in experimental murine dry eye through suppression of apoptosis. Exp Eye Res 2009;89:311–318.
- Doucet O, Lanvin M, Thillou C et al. Reconstituted human corneal epithelium: a new alternative to the Draize eye test for the assessment of the eye irritation potential of chemicals and cosmetic products. Toxicol In Vitro 2006;20:499–512.
- Van Goethem F, Adriaens E, Alépée N et al. Prevalidation of a new in vitro reconstituted human cornea model to assess the eye irritating potential of chemicals. ToxicolIn Vitro 2006;20:1–17.
- Cotovio J, Grandidier MH, Lelièvre D et al. In vitro assessment of eye irritancy using the Reconstructed Human Corneal Epithelial SkinEthic HCE model: application to 435 substances from consumer products industry. Toxicol In Vitro 2010;24:523–537.
- Nguyen DH, Beuerman RW, De Wever B et al. Alternative Toxicological Methods. (Eds.), USA: CRC Press, 2003; pp. 147–159.
- Liang H, Pauly A, Riancho L et al. Toxicological evaluation of preservative-containing and preservative-free topical prostaglandin analogues on a three-dimensional-reconstituted corneal epithelium system. Br J Ophthalmol 2011;95:869–875.
- Pauly A, Meloni M, Brignole-Baudouin F et al. Multiple endpoint analysis of the 3D-reconstituted corneal epithelium after treatment with benzalkonium chloride: early detection of toxic damage. Invest Ophthalmol Vis Sci 2009;50:1644–1652.
- Barabino S, Dana MR. Animal models of dry eye: a critical assessment of opportunities and limitations. Invest Ophthalmol Vis Sci 2004;45:1641–1646.
- Lin Z, Liu X, Zhou T et al. A mouse dry eye model induced by topical administration of benzalkonium chloride. Mol Vis 2011;17:257–264.
- Seo MJ, Kim JM, Lee MJ et al. The therapeutic effect of DA-6034 on ocular inflammation via suppression of MMP-9 and inflammatory cytokines and activation of the MAPK signaling pathway in an experimental dry eye model. Curr Eye Res 2010;35:165–175.
- Nakamura T, Sekiyama E, Takaoka M et al. The use of trehalose-treated freeze-dried amniotic membrane for ocular surface reconstruction. Biomaterials 2008;29:3729–3737.
- Teramoto N, Sachinvala ND, Shibata M. Trehalose and trehalose-based polymers for environmentally benign, biocompatible and bioactive materials. Molecules 2008;13:1773–1816.
- Meloni M, De Servi B, Marasco D et al. Molecular mechanism of ocular surface damage: application to an in vitro dry eye model on human corneal epithelium. Mol Vis 2011;17:113–126.